What is Rockwell Medical, Inc. (RMTI) stock price today?

Rockwell Medical, Inc. (RMTI) is currently trading at $7.89, down 1.62% today.

What is RMTI P/E ratio?

Rockwell Medical, Inc.'s P/E ratio is -6.22. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is RMTI return on equity (ROE)?

Rockwell Medical, Inc.'s return on equity (ROE) is -14.03%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Rockwell Medical, Inc.'s market cap?

Rockwell Medical, Inc. has a market capitalization of $31.14M.

NASDAQ · Drug Manufacturers - Specialty & Generic

Rockwell Medical, Inc. (RMTI) Stock

$7.89 -1.62% NASDAQ: RMTI Healthcare

Valuation

Metric	Value
Price	$7.89
Market Cap	$31.14M
P/E Ratio	-6.22
P/B Ratio	0.98
P/S Ratio	0.49
EPS (TTM)	$-0.15
52-Week High	$12.90
52-Week Low	$4.89
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-14.03%
ROA	-8.99%
ROCE	-9.97%
Gross Margin	-7.25%
Operating Margin	-7.25%
Net Margin	-7.33%
Debt/Equity	0.40
Current Ratio	3.80

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$62.0M	$73.0M	$84.0M	$101.0M	$69.0M
Operating Profit	$-30.0M	$-17.0M	$-7.0M	$1.0M	$-5.0M
Net Profit	$-33.0M	$-19.0M	$-8.0M	$0	$-5.0M
EPS	$-38.30	$-18.90	$-3.60	$-0.25	$-1.50
Op Margin	-49.0%	-23.1%	-8.0%	0.6%	-6.8%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$49.0M	$47.0M	$52.0M	$59.0M	$57.0M
Total Liabilities	$46.0M	$33.0M	$31.0M	$27.0M	$20.0M
Cash	$13.0M	$10.0M	$9.0M	$16.0M	$11.0M
Borrowings	$29.0M	$16.0M	$13.0M	$14.0M	$12.0M

Latest News

Rockwell Medical Advances Quality and Regulatory Leadership Business Wire · Jul 22, 2026 Rockwell Medical Regains Compliance With Nasdaq Minimum Bid Price Requirement MT Newswires · Jul 20, 2026 Rockwell Medical Regains Compliance with Nasdaq Listing Requirements Business Wire · Jul 20, 2026 Rockwell Medical to Release Second Quarter 2026 Results on Thursday, August 13, 2026 Business Wire · Jul 16, 2026 Kestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimates Zacks · Jul 14, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-34.0M	$-17.0M	$-9.0M	$4.0M	$-1.0M
Investing Cash Flow	$0	$-3.0M	$-3.0M	$-6.0M	$-9.0M
Financing Cash Flow	$0	$0	$0	$-2.0M	$-2.0M
Net Cash Flow	$-35.0M	$-3.0M	$-1.0M	$7.0M	$-5.0M
Free Cash Flow	$-34.0M	$-17.0M	$-10.0M	$3.0M	$-1.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.03
EV / EBITDA	-16.05
FCF Yield	4.51%
Quick Ratio	3.00
Interest Coverage	-3.99
Return 1Y	-48.26%
Return 3Y	-82.32%
Return 5Y	-93.07%

Ownership

Insiders Held15.12%

Institutions Held10.08%

Institutions Float Held11.87%

Institutional Holder	Shares	Report Date
Vanguard Capital Management LLC	118,236	2026-03-31
Renaissance Technologies, LLC	63,912	2026-03-31
Geode Capital Management, LLC	42,918	2026-03-31
Blackrock Inc.	23,668	2026-03-31
Vanguard Fiduciary Trust Co	23,126	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
APUSApimeds Pharmaceuticals US, Inc.	$4.69	-14.88%	-0.09	$7.08M	0.00%
ATHEAlterity Therapeutics Limited	$4.70	-5.62%	-6.89	$42.60M	0.00%
CPIXCumberland Pharmaceuticals Inc.	$7.03	+0.72%	-10.34	$105.33M	20.30%
EVAXEvaxion Biotech A/S	$3.05	+0.66%	-1.99	$19.27M	0.00%
LIMNLiminatus Pharma, Inc.	$3.70	+0.31%	-0.14	$4.97M	0.00%

About Rockwell Medical, Inc.

Rockwell Medical, Inc. is led by CEO Mark Strobeck, employs 244 people, headquartered in US, publicly traded since 1998.

Rockwell Medical, Inc. (RMTI) stock trades at $7.89 with a market capitalization of $31.14M. The stock is valued at a price-to-earnings (P/E) ratio of -6.22, price-to-book of 0.98, price-to-sales of 0.49. Over the past 52 weeks the stock has ranged between $4.89 and $12.90, and currently trades 38.8% below its 52-week high.

On profitability, Rockwell Medical, Inc. generates a return on equity (ROE) of -14.03%, return on capital employed of -9.97%, an operating margin of -7.25%, a net profit margin of -7.33%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.31 +0.33% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides